A carregar...

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines

Invariant natural killer T (iNKT) cells have the capacity to amplify adaptive immune responses by licensing antigen-presenting cells. A simple vaccine consisting of whole tumor cells pulsed with an iNKT-cell agonist efficiently delivers antigens plus adjuvants to endogenous dendritic cells and has p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hunn, Martin K., Hermans, Ian F.
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654595/
https://ncbi.nlm.nih.gov/pubmed/23734325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23789
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!